Patterns in Pain and Opiate Use after Endoscopic Sinus Surgery.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 32284006.
- Also identified by DOI 10.1177/0194599820915472.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate postoperative opiate use and patients' opinions regarding pain management after endoscopic sinus surgery (ESS). Case series with planned data collection. Tertiary referral medical center. We prospectively evaluated postoperative opiate utilization in adults undergoing ESS over a 2-year period at an academic medical facility. Exclusion criteria included use of nasal packing, intracranial or orbital procedures, tumor surgery, and any use of endoscopic drills. All patients underwent bilateral maxillary antrostomy, total ethmoidectomy, sphenoidotomy, and frontal sinusotomy with or without septoplasty. Patients were discharged with 30 oxycodone-acetaminophen (5-325 mg) and a survey assessing pain and narcotic/nonnarcotic use on postoperative days 0 to 7. A total of 64 patients completed surveys. Mean ± SD narcotic use over the 7-day postoperative period was 7.7 ± 7.6 pills. Patients with high narcotic use (>6 pills total) had no differences in demographic or surgical factors from those with low use (≤6 pills) but did report a higher level of postoperative day 1 pain (4.8 ± 1.1 vs 2.0 ± 1.4, <i>P</i> < .001). Narcotic use declined during this period, with <30% of patients requiring narcotics by postoperative day 3. Our results support reduced opiate prescription and encouragement of nonnarcotic use after ESS without compromising effective pain management.
Medical subject headings
- Analgesics, Opioid
- Endoscopy
- Ethmoid Sinus
- Frontal Sinus
- Pain Management
- Postoperative Pain
- Prescription Drugs